Effect of two drugs(granulocyte colony stimulating factor and erythropoietin combination) on bleeding from the upper gastrointestinal tract with underlying liver disease
Phase 2
- Conditions
- Health Condition 1: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2021/03/032466
- Lead Sponsor
- JIPMERpuducherry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients above 18 years of age being evaluated for upper gastrointestinal bleed with underlying liver cirrhosis in the department of surgery, JIPMER
Exclusion Criteria
Age <18 or >75 years, suspected autoimmune hepatitis,hepatocellular carcinoma, any focus of sepsis,multi- organ dysfunction, grade 3 or 4 hepatic encephalopathy, HIV seropositivity, pregnancy, uncontrolled hypertension, coronary artery disease,planned for liver transplantation, refusal to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method